journal article·2026-01-13Open access

Functional Peptide-Based Biomaterials for Pharmaceutical Application: Sequences, Mechanisms, and Optimization Strategies

Dedong Yu, Nari Han, Hyejeong Son, Sun Jo Kim, Seho Kweon

Abstract

Peptide-based biomaterials have emerged as versatile tools for pharmaceutical drug delivery due to their biocompatibility and tunable sequences, yet a comprehensive overview of their categories, mechanisms, and optimization strategies remains lacking to guide clinical translation. This review systematically collates advances in peptide-based biomaterials, covering peptide excipients (cell penetrating peptides, tight junction modulating peptides, and peptide surfactants/stabilizers), self-assembling peptides (peptide-based nanospheres, cyclic peptide nanotubes, nanovesicles and micelles, peptide-based hydrogels and depots), and peptide linkers (for antibody drug-conjugates, peptide drug-conjugates, and prodrugs). We also dissect sequence-based optimization strategies, including rational design and biophysical optimization (cyclization, stapling, D-amino acid incorporation), functional motif integration, and combinatorial discovery with AI assistance, with examples spanning marketed drugs and research-stage candidates. The review reveals that cell-penetrating peptides enable efficient intracellular payload delivery via direct penetration or endocytosis; self-assembling peptides form diverse nanostructures for controlled release; and peptide linkers achieve site-specific drug release by responding to tumor-associated enzymes or pH cues, while sequence optimization enhances stability and targeting. Peptide-based biomaterials offer precise, biocompatible and tunable solutions for drug delivery, future advancements relying on AI-driven design and multi-functional modification will accelerate their transition from basic research to clinical application.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Supramolecular Self-Assembly in Materials · RNA Interference and Gene Delivery · Hydrogels: synthesis, properties, applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Pharmacy, Chonnam National University, Gwangju 61186, Republic of Korea

Funding

Chonnam National University

References (100+)

Show source-provided references
1. van der Merwe, J., Steenekamp, J., Steyn, D., and Hamman, J. (2020). The Role of Functional Excipients in Solid Oral Dosage Forms to Overcome Poor Drug Dissolution and Bioavailability. Pharmaceutics, 12.10.3390/pharmaceutics12050393 ↗
2. Challenges in delivering therapeutic peptides and proteins: A silk-based solution10.1016/j.jconrel.2022.02.011 ↗
3. Migoń, D., Jaremicz, Z., and Kamysz, W. (2025). Short Peptides as Excipients in Parenteral Protein Formulations: A Mini Review. Pharmaceutics, 17.10.3390/pharmaceutics17101328 ↗
4. Rigid linker peptides improve the stability and anti-inflammation effect of human serum albumin and alpha-melanocyte-stimulating hormone fusion proteins10.1002/biot.202300502 ↗
5. Hydrophobicity is a key determinant in the activity of arginine-rich cell penetrating peptides10.1038/s41598-022-20425-y ↗
6. Contribution of Secondary Structure Changes to the Surface Activity of Proteins10.1016/j.jbiotec.2020.07.015 ↗
7. pH-Responsive Self-Assembling Peptide-Based Biomaterials: Designs and Applications10.1021/acsabm.2c00188 ↗
8. Recent Advances in Peptide Linkers for Antibody-Drug Conjugates10.1021/acs.jmedchem.5c01982 ↗
9. Cell penetrating peptides: A concise review with emphasis on biomedical applications10.1016/j.biopha.2018.09.097 ↗
10. Cell-penetrating peptides (CPPs): From delivery of nucleic acids and antigens to transduction of engineered nucleases for application in transgenesis10.1016/j.jbiotec.2017.05.002 ↗
11. Prospect of cell penetrating peptides in stem cell tracking10.1186/s13287-021-02522-3 ↗
12. Corrigendum to ‘Cell-penetrating peptides in protein mimicry and cancer therapeutics’ [Advanced Drug Delivery Reviews, 180 (2022), 114044]10.1016/j.addr.2022.114128 ↗
13. Rate-limiting transport of positively charged arginine residues through the Sec-machinery is integral to the mechanism of protein secretion10.7554/eLife.77586 ↗
14. Liu, B.R., Chiou, S.H., Huang, Y.W., and Lee, H.J. (2022). Bio-Membrane Internalization Mechanisms of Arginine-Rich Cell-Penetrating Peptides in Various Species. Membranes, 12.10.3390/membranes12010088 ↗
15. Impact of Chirality and Position of Lysine Conjugation in Triplex-Forming Peptide Nucleic Acids10.1021/acsomega.0c04021 ↗
16. Lysine acetylation regulates the interaction between proteins and membranes10.1038/s41467-021-26657-2 ↗
17. Borrelli, A., Tornesello, A.L., Tornesello, M.L., and Buonaguro, F.M. (2018). Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents. Molecules, 23.10.3390/molecules23020295 ↗
18. Spotlight on HIV-derived TAT peptide as a molecular shuttle in drug delivery10.1016/j.drudis.2024.104191 ↗
19. A branched TAT cell-penetrating peptide as a novel delivery carrier for the efficient gene transfection10.1186/s40824-016-0076-0 ↗
20. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors10.1073/pnas.151247498 ↗
21. Martin, M.U., Frevert, J., and Tay, C.M. (2024). Complexing Protein-Free Botulinum Neurotoxin A Formulations: Implications of Excipients for Immunogenicity. Toxins, 16.10.3390/toxins16020101 ↗
22. Intelligent “Peptide-Gathering Mechanical Arm” Tames Wild “Trojan-Horse” Peptides for the Controlled Delivery of Cancer Nanotherapeutics10.1021/acsami.7b15523 ↗
23. Rational modification of oligoarginine for highly efficient siRNA delivery: Structure-activity relationship and mechanism of intracellular trafficking of siRNA10.1016/j.nano.2014.08.007 ↗
24. Structure-activity relationship study of the cell-penetrating peptide pVEC10.1016/j.bbamem.2006.05.013 ↗
25. Library screening of cell-penetrating peptide for BY-2 cells, leaves of Arabidopsis, tobacco, tomato, poplar, and rice callus10.1038/s41598-018-29298-6 ↗
26. Cationic and amphipathic cell-penetrating peptides (CPPs): Their structures and in vivo studies in drug delivery10.1007/s11705-015-1538-y ↗
27. Effects of N-terminal and C-terminal modification on cytotoxicity and cellular uptake of amphiphilic cell penetrating peptides10.1080/21691401.2017.1414823 ↗
28. Kardani, K., Hashemi, A., and Bolhassani, A. (2019). Comparison of HIV-1 Vif and Vpu accessory proteins for delivery of polyepitope constructs harboring Nef, Gp160 and P24 using various cell penetrating peptides. PLoS ONE, 14.10.1371/journal.pone.0223844 ↗
29. Cell-Penetrating Peptides: From Basic Research to Clinics10.1016/j.tips.2017.01.003 ↗
30. Recent advances in de novo protein design: Principles, methods, and applications10.1016/j.jbc.2021.100558 ↗
31. Silva, S., Kurrikoff, K., Langel, U., Almeida, A.J., and Vale, N. (2022). A Second Life for MAP, a Model Amphipathic Peptide. Int. J. Mol. Sci., 23.10.3390/ijms23158322 ↗
32. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy10.1021/mp200481g ↗
33. A molecular dynamics study of cell-penetrating peptide transportan-10 (TP10): Binding, folding and insertion to transmembrane state in zwitterionic membrane10.1016/j.bbamem.2023.184218 ↗
34. Understanding Cell Penetration of Cyclic Peptides10.1021/acs.chemrev.9b00008 ↗
35. Birch, D., Sayers, E.J., Christensen, M.V., Jones, A.T., Franzyk, H., and Nielsen, H.M. (2023). Stereoisomer-Dependent Membrane Association and Capacity for Insulin Delivery Facilitated by Penetratin. Pharmaceutics, 15.10.3390/pharmaceutics15061672 ↗
36. Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines10.1038/s41598-019-42456-8 ↗
37. Biotherapeutic effect of cell-penetrating peptides against microbial agents: A review10.1080/21688370.2021.1995285 ↗
38. Proline-rich peptides: Multifunctional bioactive molecules as new potential therapeutic drugs10.2174/1389203716666150102110817 ↗
39. An l- to d-Amino Acid Conversion in an Endosomolytic Analog of the Cell-penetrating Peptide TAT Influences Proteolytic Stability, Endocytic Uptake, and Endosomal Escape10.1074/jbc.M116.759837 ↗
40. Membrane Molecular Interactions and Induced Structures of CPPs10.1007/978-1-0716-1752-6_10 ↗
41. Pulmonary surfactant model systems catch the specific interaction of an amphiphilic peptide with anionic phospholipid10.1016/j.bpj.2008.11.022 ↗
42. Amyloid-like Self-Assembly of a Hydrophobic Cell-Penetrating Peptide and Its Use as a Carrier for Nucleic Acids10.1021/acsabm.1c00601 ↗
43. Repurposing a peptide toxin from wasp venom into antiinfectives with dual antimicrobial and immunomodulatory properties10.1073/pnas.2012379117 ↗
44. Direct cytosolic delivery of polar cargo to cells by spontaneous membrane-translocating peptides10.1074/jbc.M113.488312 ↗
45. Cell-penetrating peptides (CPPs): An overview of applications for improving the potential of nanotherapeutics10.1039/D0BM01755H ↗
46. Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications
47. Structural Elucidation of the Cell-Penetrating Penetratin Peptide in Model Membranes at the Atomic Level: Probing Hydrophobic Interactions in the Blood-Brain Barrier10.1021/acs.biochem.6b00518 ↗
48. Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin10.1038/s41598-019-40103-w ↗
49. de Santana, C.J.C., Pires Junior, O.R., Fontes, W., Palma, M.S., and Castro, M.S. (2022). Mastoparans: A Group of Multifunctional alpha-Helical Peptides With Promising Therapeutic Properties. Front. Mol. Biosci., 9.10.3389/fmolb.2022.824989 ↗
50. Regulation of the intestinal barrier by nutrients: The role of tight junctions10.1111/asj.13357 ↗
51. Morphologic determinant of tight junctions revealed by claudin-3 structures10.1038/s41467-019-08760-7 ↗
52. Occludin regulation of blood-brain barrier and potential therapeutic target in ischemic stroke10.4103/bc.bc_29_20 ↗
53. Role of zonula occludens in gastrointestinal and liver cancers10.12998/wjcc.v10.i12.3647 ↗
54. Biomaterial-tight junction interaction and potential impacts10.1039/C9TB01081E ↗
55. Target specific tight junction modulators10.1016/j.addr.2021.02.008 ↗
56. Claudin-1-Targeted Nanoparticles for Delivery to Aging-Induced Alterations in the Blood-Brain Barrier10.1021/acsnano.1c08432 ↗
57. Structural basis for Clostridium perfringens enterotoxin targeting of claudins at tight junctions in mammalian gut10.1073/pnas.2024651118 ↗
58. Claudin-9 structures reveal mechanism for toxin-induced gut barrier breakdown10.1073/pnas.1908929116 ↗
59. Modifying the blood-brain barrier by targeting claudin-5: Safety and risks10.1111/nyas.14787 ↗
60. A claudin5-binding peptide enhances the permeability of the blood-brain barrier in vitro10.1126/sciadv.adq2616 ↗
61. Lialios, P., and Alimperti, S. (2025). Role of E-cadherin in epithelial barrier dysfunction: Implications for bacterial infection, inflammation, and disease pathogenesis. Front. Cell. Infect. Microbiol., 15.10.3389/fcimb.2025.1506636 ↗
62. Modulation of intercellular junctions by cyclic-ADT peptides as a method to reversibly increase blood-brain barrier permeability10.1002/jps.24309 ↗
63. Tight junctions: From molecules to gastrointestinal diseases10.1080/21688370.2022.2077620 ↗
64. Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges10.1021/acs.molpharmaceut.2c00523 ↗
65. Mechanism of the blood-brain barrier modulation by cadherin peptides10.37349/eds.2024.00049 ↗
66. PD-L1-Targeting Biomimetic Photoresponsive Thermosensitive Liposomes for Triple-Negative Breast Cancer10.1002/advs.202506841 ↗
67. Alginate-pectin microparticles embedding self-assembling antimicrobial peptides and resveratrol for antimicrobial and anti-inflammatory applications10.1016/j.foodhyd.2025.111454 ↗
68. Self-assembly of antimicrobial peptide-based micelles breaks the limitation of trypsin10.1021/acsami.2c17941 ↗
69. Self-assembling peptide nanofiber hydrogels in tissue engineering and regenerative medicine: Progress, design guidelines, and applications10.1002/jbm.a.35638 ↗
70. Self-assembling peptide-based hydrogels in angiogenesis10.2147/IJN.S277046 ↗
71. Self-assembling peptide RADA16 nanofiber scaffold hydrogel-wrapped concentrated growth factors in osteogenesis of MC3T310.3390/jfb14050260 ↗
72. Self-assembling peptide nanofibers anchored parathyroid hormone derivative for bone tissue engineering10.1007/s42765-023-00370-9 ↗
73. Peptide Self-Assembly into Amyloid Fibrils at Hard and Soft Interfaces—From Corona Formation to Membrane Activity10.1002/mabi.202200576 ↗
74. Liu, B., Zhang, H., and Qin, X. (2025). Amyloid Fibrils and Their Applications: Current Status and Latest Developments. Nanomaterials, 15.10.3390/nano15040255 ↗
75. Hydrogen bonding stiffens peptide amphiphile supramolecular filaments by aza-glycine residues10.1016/j.actbio.2021.08.044 ↗
76. Structure-Based Programming of Supramolecular Assemblies in Living Cells for Selective Cancer Cell Inhibition10.1002/anie.202103507 ↗
77. Dissecting electrostatic contributions to folding and self-assembly using designed multicomponent peptide systems10.1021/jacs.5b10304 ↗
78. A sublingual nanofiber vaccine to prevent urinary tract infections10.1126/sciadv.abq4120 ↗
79. Symmetry-directed self-organization in peptide nanoassemblies through aromatic π–π interactions10.1021/acs.jpcb.6b09474 ↗
80. On the pathway of the formation of secondary structures in proteins10.1002/prot.26591 ↗
81. Site-selective modification of peptide backbones10.1039/D1QO00892G ↗
82. Role and modulation of the secondary structure of antimicrobial peptides to improve selectivity10.1039/D0BM00801J ↗
83. Supramolecular peptide nano-assemblies for cancer diagnosis and therapy: From molecular design to material synthesis and function-specific applications10.1186/s12951-021-00999-x ↗
84. Quick photofabrication of functional nanospheres from de novo designed peptides for NIR fluorescence and MR imaging10.1007/s12274-022-4826-0 ↗
85. Alliance with EPR effect: Combined strategies to improve the EPR effect in the tumor microenvironment10.7150/thno.37198 ↗
86. Cyclic peptides nanospheres: A ‘2-in-1′ self-assembled delivery system for targeting nucleus and cytoplasm10.1016/j.ejps.2022.106125 ↗
87. Peptide-triggered self-assembly of collagen mimetic peptides into nanospheres by electrostatic interaction and π–π stacking10.1039/D3TB00088E ↗
88. Sound-driven dissipative self-assembly of aromatic biomolecules into functional nanoparticles10.1039/C9NH00611G ↗
89. cRGD peptide-installed epirubicin-loaded polymeric micelles for effective targeted therapy against brain tumors10.1016/j.jconrel.2017.04.033 ↗
90. Combined biomimetic MOF-RVG15 nanoformulation efficient over BBB for effective anti-glioblastoma in mice model10.2147/IJN.S387715 ↗
91. tLyP-1-conjugated core-shell nanoparticles, Fe3O4NPs@ mSiO2, for tumor-targeted drug delivery10.1016/j.apsusc.2018.09.205 ↗
92. Amplified cancer immunotherapy of PD-L1 blockade by sequential tumor microenvironment reshaping and DC maturation10.1016/j.cej.2022.139795 ↗
93. Shirazi, A.N., Park, S.E., Rad, S., Baloyan, L., Mandal, D., Sajid, M.I., Hall, R., Lohan, S., Zoghebi, K., and Parang, K. (2020). Cyclic peptide-gadolinium nanoparticles for enhanced intracellular delivery. Pharmaceutics, 12.10.3390/pharmaceutics12090792 ↗
94. Fabrication of fluorescent nanospheres by heating PEGylated tetratyrosine nanofibers10.1038/s41598-020-79396-7 ↗
95. Thongpon, P., Tang, M., and Cong, Z. (2025). Peptide-Based Nanoparticle for Tumor Therapy. Biomedicines, 13.10.3390/biomedicines13061415 ↗
96. Lee, V.H., Traver, R.D., and Taub, M.E. (2024). Enzymatic barriers to peptide and protein drug delivery. Peptide and Protein Drug Delivery, CRC Press.10.1201/9781003573715 ↗
97. Structural control of self-assembled peptide nanostructures to develop peptide vesicles for photodynamic therapy of cancer10.1016/j.mtbio.2022.100337 ↗
98. Self-assembly of peptides to nanostructures10.1039/C4OB00447G ↗
99. Self-assembled nanotubes from the supramolecular polymerization of discrete cyclic entities10.1039/D4CS01273A ↗
100. Molecular insights on the cyclic peptide nanotube-mediated transportation of antitumor drug 5-fluorouracil10.1021/mp100274f ↗